Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06711458 · ClinicalTrials.gov registry record · NA
Using Generative Artificial Intelligence (AI) to Create Patient-Friendly Discharge Summaries
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT06711458: Completed NA study, sponsored by NYU Langone Health.
NCT06711458 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06711458, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
This will be an open-label, parallel-group, randomized trial. Patients will be randomized to review the patient-friendly discharge instructions at the time of discharge (intervention group) vs the standard of care. The intervention differs from the standard of care in that patients will be given additional medical documentation in the intervention group.
Primary Outcome
This is a composite outcome measure. Readability of discharge summaries will be measured using the Flesch-Kincaid Grade Level assessment, which measures how challenging a text may be for readers. Scores on the Flesch-Kincaid assessment are rated as follows: 0-3: Basic reading level, (kindergarten or elementary school) 3-6: Basic reading level, (elementary school ) 6-9: Average reading level, (middle school) 9-12: Average reading level, (high school) 11-18: Skilled readers. Understandability wi
Interventions
- BEHAVIORAL AI-Generated Discharge Instructions
- BEHAVIORAL Standard of Care Discharge Instructions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2025-01-29 |
| Est. Completion | 2025-05-22 |
| Phase | NA |
What the finished NCT06711458 record still lists
NCT06711458 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which AI-Generated Discharge Instructions is the first listed.
NCT06711458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06711458 about?
NCT06711458 is a clinical study titled "Using Generative Artificial Intelligence (AI) to Create Patient-Friendly Discharge Summaries". This will be an open-label, parallel-group, randomized trial. Patients will be randomized to review the patient-friendly discharge instructions at the time of discharge (intervention group) vs the standard of care. The intervention differs from the standard of care in that patients will be given add...
What is the current status of trial NCT06711458?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2025-01-29. Estimated completion is 2025-05-22.
What interventions are being tested in trial NCT06711458?
The interventions under investigation include: AI-Generated Discharge Instructions (BEHAVIORAL), Standard of Care Discharge Instructions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06711458?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06711458's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI